This unique 1-year Medical Affairs fellowship program in a biotechnology company provides fellows an opportunity to gain hands-on experience contributing to the various functional areas within Medical Affairs. By serving as an integral member of the Medical Affairs team, the fellow will gain a deep understanding of the science behind gene therapy as it applies to Spark Therapeutics' areas of focus, as well as the interplay between different functions within a biotechnology company.
The program includes three mandatory rotations: Medical Information (5 months), Field Medical Affairs—Medical Science Liaison (5 months), Medical Communications (2 months). Potential opportunities to assist other internal stakeholders with projects will be determined on a case-to-case basis, but are highly encouraged.
Understand the role and responsibilities of a Medical Information Specialist in a biotechnology company
Create and provide timely, accurate, and balanced medical/scientific and technical information in response to inquiries from healthcare professionals, consumers, and managed care organizations with standard and customized response documents, scientific slide decks, and clinical dossiers
Provide a high-quality review of promotional and medical materials to ensure medical and scientific accuracy and balance
Attend relevant scientific meetings to provide staffing support when assigned for the Medical Information booths at scientific conventions
Medical Science Liaison
Collaborate with Medical Affairs and cross-functional team members on core project imperatives
Learn the core functions of a Medical Science Liaison through competency training and assist in developing and delivering effective clinical presentations to internal and external stakeholders, establishing and maintaining scientifically grounded, peer-to-peer relationships with key opinion leaders (KOLs), and optimizing communication of key insights from the field back to the team
Collaborate with medical directors, medical communications and vendors in the creation and revision of field medical resources and training materials
Play a critical role in field medical operations, assisting in the development of insight reports, territory plans, and optimizing field medical use of a customer relationship management tool to track KOL interactions
Understand the congress planning process from identification of relevant content to attending the meeting and enhancing knowledge of gene therapy as it applies to Spark Therapeutics' areas of focus, through delivering a summary of activity and learnings back to the team
Understand the role and skills required of a Medical Communications Professional as a specialized Medical Affairs function in the biotechnology industry
Collaborate with Medical Affairs team members and cross-functional partners to develop a plan that supports strategic and tactical communication of scientific data
Develop a thorough understanding of the core principles of Good Publications Practices (GPP3) for industry-based publications and work through the development of a publication, starting with concept development to submission to a publications platform (scientific journal or congress)
Learn how to develop a team-based comprehensive congress plan that incorporates strategic objectives and the derivative tactics
Learn the principles of project management and prioritization in the context of medical communication
Candidates must have a Doctor of Pharmacy degree from an ACPE-accredited school or college prior to their start date.
Ability to legally work in the US for the duration of the program
Candidates who are selected for onsite interviews will need to provide:
Official pharmacy school transcript
Two formal letters of recommendation sent to MedicalAffairsFellowship@SparkTX.com
About Spark Therapeutics Inc.
Founded in March 2013 as a result of the technology and know-how accumulated over two decades at Children’s Hospital of Philadelphia (CHOP), Spark Therapeutics is a publicly traded, late clinical-stage gene therapy company. Its investigational therapies have the potential to provide long-lasting effects, dramatically and positively changing the lives of patients with conditions where no, or only palliative, therapies exist. Greater understanding of the human genome and genetic abnormalities have allowed our scientists to tailor investigational therapies to patients suffering from very specific genetic diseases. This approach holds great promise in developing effective treatments to a host of inherited diseases. Our initial focus is on treating orphan diseases.
Headquartered in dynamic Philadelphia, we are a diverse, experienced team united in our goal to break down barriers for people and families affected by genetic diseases. As our name suggests, our investigational, one-time therapies are designed to spark healthy biology, and deliver potentially life-altering transformation for people and families affected by genetic disease.